n Southern African Journal of HIV Medicine - From the editor




Recent weeks have borne witness to controversies relating to the pricing of antiretroviral drugs, and it is heartening that at long last the voice of reason has prevailed and access to optimal therapies for our patients is on the horizon. The availability of cheap drugs, although crucial to treatment access initiatives, is by no means the only prerequisite that needs to be in place before patients get treatment.


Article metrics loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error